Bone Drug Linked to Jaw Disease

Staff Writer
Contributor
Posted by Staff WriterJune 02, 2006 2:25 PM

A month after I blogged about Fosamax, the NY Times has run a front page story on the horrible dilemma facing patients with cancer or osteoporosis. The FDA has now required bisphosphonate labels to disclose the serious side effects of death of areas of bone in the jaw, which may occur in one of 10 patients who take the drug. Pharmaceutical companies are defending about 20 suits filed so far by denying that osteonecrosis occurred in their clinical trials. This is scary stuff.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Chicago

InjuryBoard Chicago RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Chicago is brought to you by Gary D. McCallister & Associates

Legal Assistance Center

More Info
Gary D. McCallister & Associates (866) 735-1102 Ext 625 www.gdmlawfirm.com
google
Personal Injury Lawyers Serving: Chicago, Arlington Heights, Aurora, Beardstown, Cicero, DeKalb, Des Plains, Elgin, Evanston, Jacksonville, Jerseyville, Mount Prospect, Oak Lawn, Palatine, Pittsfield, Quincy, Schaumburg, Skokie, Springfield, St. Charles, Tinley Park
120 North LaSalle StreetSuite 2800, Chicago, Illinois 60602 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address